Showing results (381-390 of 831) with videos related to

Sort By:
Pageof 84
Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Decitabine can be safely reduced after achievement of best objective response in patients with myelodysplastic syndromeHady Ghanem, A Megan Cornelison, Guillermo Garcia-Manero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Long-term Follow-up of Treatment with Ibrutinib and Rituximab in Patients with High-Risk Chronic Lymphocytic LeukemiaPreetesh Jain, Michael J Keating, William G Wierda, et al.
Cancer|February 6, 2014
Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemiaKatja Karjalainen, Renata Pasqualini, Jorge E Cortes, et al.
Blood|May 16, 2014
Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinibDominik Wodarz, Naveen Garg, Natalia L Komarova, et al.
British Journal of Haematology|March 8, 2008
Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patientsConstantine S Tam, Joselle Otero-Palacios, Lynne V Abruzzo, et al.
Cytometry. Part B, Clinical Cytometry|June 23, 2010
CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entityRoxana S Dronca, Dragan Jevremovic, Curtis A Hanson, et al.
Leukemia & Lymphoma|October 9, 2009
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosisClive S Zent, Wei Ding, Megan S Reinalda, et al.
Cancer|June 25, 2005
2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndromeElias Jabbour, Srdan Verstovsek, Francis Giles, et al.
Cancer|June 23, 2005
Significance of myelofibrosis in early chronic-phase, chronic myelogenous leukemia on imatinib mesylate therapyHagop M Kantarjian, Carlos E Bueso-Ramos, Moshe Talpaz, et al.
Cancer|March 7, 2006
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemiaMaher Albitar, Steven J Potts, Francis J Giles, et al.
Pageof 84